-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, ENdn5RNc5H9byqVFLOAhijw2KT2M+M3UZ3tWdR3eTSDWp6Huv+cByRx6v2wgEE2D RmjwrmAjYb5ToxjNNT1QEQ== 0001265855-10-000003.txt : 20100701 0001265855-10-000003.hdr.sgml : 20100701 20100701172932 ACCESSION NUMBER: 0001265855-10-000003 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20100701 FILED AS OF DATE: 20100701 DATE AS OF CHANGE: 20100701 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SOPER STANLEY E CENTRAL INDEX KEY: 0001265855 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-23731 FILM NUMBER: 10931813 MAIL ADDRESS: STREET 1: C/O NUTRACEUTICAL INTERNATIONAL CORP STREET 2: 1400 KEARNS BLVD 2ND FL. CITY: PARK CITY STATE: UT ZIP: 84060 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NUTRACEUTICAL INTERNATIONAL CORP CENTRAL INDEX KEY: 0001050007 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 870515089 STATE OF INCORPORATION: DE FISCAL YEAR END: 0930 BUSINESS ADDRESS: STREET 1: 1400 KEARNS BOULEVARD STREET 2: 2ND FLOOR CITY: PARK CITY STATE: UT ZIP: 84060 BUSINESS PHONE: 4356556000 MAIL ADDRESS: STREET 1: 1400 KEARNS BOULEVARD STREET 2: 2ND FLOOR CITY: PARK CITY STATE: UT ZIP: 84060 4 1 primary_doc.xml PRIMARY DOCUMENT X0303 4 2010-07-01 0 0001050007 NUTRACEUTICAL INTERNATIONAL CORP NUTR 0001265855 SOPER STANLEY E C/O NUTRACEUTICAL INTERNATIONAL CORP 1400 KEARNS BLVD 2ND FL. PARK CITY UT 84060 0 1 0 0 VP, Legal Affairs Common Stock 2010-07-01 4 M 0 6000 2.4375 A 21237.7106 D Common Stock 2010-07-01 4 S 0 6000 14.9625 D 15237.7106 D Employee Stock Option (right to buy) 2.4375 2010-07-01 4 M 0 6000 0 D 2011-03-05 Common Stock 6000 8000 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 11, 2010. The price shown in Column 4 is a weighted average sale price. The price range for the sales is $14.73 to $15.245. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. The option vested in six equal installments every six months beginning on September 5, 2001. /s/ Alison Pitt, attorney in fact 2010-07-01 -----END PRIVACY-ENHANCED MESSAGE-----